Author:
Maffeis Claudio,Olivieri Francesca,Valerio Giuliana,Verduci Elvira,Licenziati Maria Rosaria,Calcaterra Valeria,Pelizzo Gloria,Salerno Mariacarolina,Staiano Annamaria,Bernasconi Sergio,Buganza Raffaele,Crinò Antonino,Corciulo Nicola,Corica Domenico,Destro Francesca,Di Bonito Procolo,Di Pietro Mario,Di Sessa Anna,deSanctis Luisa,Faienza Maria Felicia,Filannino Grazia,Fintini Danilo,Fornari Elena,Franceschi Roberto,Franco Francesca,Franzese Adriana,Giusti Lia Franca,Grugni Graziano,Iafusco Dario,Iughetti Lorenzo,Lera Riccardo,Limauro Raffaele,Maguolo Alice,Mancioppi Valentina,Manco Melania,Del Giudice Emanuele Miraglia,Morandi Anita,Moro Beatrice,Mozzillo Enza,Rabbone Ivana,Peverelli Paola,Predieri Barbara,Purromuto Salvo,Stagi Stefano,Street Maria Elisabeth,Tanas Rita,Tornese Gianluca,Umano Giuseppina Rosaria,Wasniewska Malgorzata
Abstract
AbstractThis Position Statement updates the different components of the therapy of obesity (lifestyle intervention, drugs, and surgery) in children and adolescents, previously reported in the consensus position statement on pediatric obesity of the Italian Society of Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics. Lifestyle intervention is the first step of treatment. In children older than 12 years, pharmacotherapy is the second step, and bariatric surgery is the third one, in selected cases. Novelties are available in the field of the medical treatment of obesity. In particular, new drugs demonstrated their efficacy and safety and have been approved in adolescents. Moreover, several randomized control trials with other drugs are in process and it is likely that some of them will become available in the future. The increase of the portfolio of treatment options for obesity in children and adolescents is promising for a more effective treatment of this disorder.
Publisher
Springer Science and Business Media LLC